Melanotic neuroectodermal tumor of infancy to the skull: case-based review

Florian Ebel1, Florian M Thieringer2,3,4, Christoph Kunz2,4

  • 1Department of Neurosurgery, University Hospital of Basel, Basel, Switzerland. florianebel@hotmail.com.

Abstract

Insights

Melanotic neuroectodermal tumor of infancy (MNTI) is a rare condition in infants. Radical surgery is crucial for cure, but reconstruction in infants presents challenges.

Area of Science:

  • Pediatric Oncology
  • Craniofacial Surgery
  • Molecular Pathology

Background:

  • Melanotic neuroectodermal tumor of infancy (MNTI) is a rare neoplasm typically affecting infants under one year old.
  • Early diagnosis and complete surgical resection are vital for achieving a long-term cure.

Observation:

  • A case of a 4-month-old boy with a rapidly growing MNTI involving the skull base is presented.
  • The tumor infiltrated the sphenoid wing, frontotemporal bone, orbit, and dura mater.
  • Initial fine needle biopsy excluded sarcoma, leading to diagnosis.

Findings:

  • Complete tumor excision was achieved, followed by cranial reconstruction using absorbable plates and Tutobone.
  • Histology confirmed MNTI, with molecular analysis revealing high similarity to medulloblastoma group 3.
  • A local recurrence necessitated chemotherapy and a second surgery, followed by management of pseudomeningocele and further reconstruction.

Implications:

  • Radical surgery remains the gold standard for MNTI to minimize recurrence.
  • Reconstruction following MNTI resection in infants is complex due to the tumor's destructive growth.
  • This case highlights the challenges and management strategies for MNTI in infants, including surgical reconstruction and recurrence treatment.